Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review

References

• Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–3785.
   PubMed Web of Science ®Google Scholar
• Alberti-Violetti S, Torres-Cabala CA, Talpur R, et al. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma. J Cutan Pathol. 2016;43(12):1121–1130.
   PubMed Web of Science ®Google Scholar
• Keeling BH, Gavino ACP, Admirand J, et al. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: report of a case and review of the literature. J Cutan Pathol. 2017;44(11):944–947.
   PubMed Web of Science ®Google Scholar
• Grange BF, Hedelin G, Joly P, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis. Blood. 1999;93(11):3637–3642.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2391.
   PubMed Web of Science ®Google Scholar
• Beltzung F, Ortonne N, Pelletier L, et al. Primary cutaneous CD4 + small/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60 cases presenting with a single lesion: a multicenter study of the French Cutaneous Lymphoma Study Group. Am J Surg Pathol. 2020;44(7):862–872.
   PubMed Web of Science ®Google Scholar
• Goddard AL, Vleugels RA, LeBoeuf NR, et al. Palliative therapy for recalcitrant cutaneous T-cell lymphoma of the hands and feet with low-dose, high dose-rate brachytherapy. JAMA Dermatol. 2015;151(12):1354–1357.
   PubMed Web of Science ®Google Scholar
• Schwarz JK, Beriwal S, Esthappan J, et al. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy. 2015;14(5):587–599.
   PubMed Web of Science ®Google Scholar
• Ally MS, Prasad Hunasehally RY, Rodriguez-Justo M, et al. Evaluation of follicular T-helper cells in primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma and dermatitis. J Cutan Pathol. 2013;40(12):1006–1013.
   PubMed Web of Science ®Google Scholar
• Grogg KL, Jung S, Erickson LA, et al. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. 2008;21(6):708–715.
   PubMed Web of Science ®Google Scholar
• Magro CM, Olson LC, Fulmer CG. CD30 + T cell enriched primary cutaneous CD4 + small/medium sized pleomorphic T cell lymphoma: a distinct variant of indolent CD4 + T cell lymphoproliferative disease. Ann Diagn Pathol. 2017;30:52–58.
   PubMed Web of Science ®Google Scholar
• Bekkenk MW, Vermeer MH, Jansen PM, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood. 2003;102(6):2213–2219.
   PubMed Web of Science ®Google Scholar
• Krenács D, Bakos A, Török L, et al. Neoplastic cells of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma lack the expression of follicular T-helper cell defining chemokine receptor CXCR5. Acta Derm Venereol. 2016;96(6):850–852.
   PubMed Web of Science ®Google Scholar
• Weaver J, Mahindra AK, Pohlman B, et al. Non-mycosis fungoides cutaneous T-cell lymphoma: Reclassification according to the WHO-EORTC classification. J Cutan Pathol. 2010;37(5):516–524.
   PubMed Web of Science ®Google Scholar
• Friedmann D, Wechsler J, Delfau M-H, et al. Primary cutaneous pleomorphic small T-Cell lymphoma. Arch Dermatol. 1995;131(9):1009–1015.
   PubMedGoogle Scholar
• Yuan Z, Grass GD, Robinson TJ, et al. Management of primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a retrospective study. J Am Acad Dermatol. 2018;79(4):772–774.
   PubMed Web of Science ®Google Scholar
• Baum CL, Link BK, Neppalli VT, et al. Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature. J Am Acad Dermatol. 2011;65(4):739–748.
   PubMed Web of Science ®Google Scholar
• Jenni D, Karpova MB, Seifert B, et al. Primary cutaneous lymphoma: Two-decade comparison in a population of 263 cases from a Swiss tertiary referral Centre. Br J Dermatol. 2011;164(5):1071–1077.
   PubMed Web of Science ®Google Scholar
• Sterry W, Siebel A, Mielke V. HTLV‐1‐negative pleomorphic T‐cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients. Br J Dermatol. 1992;126(5):456–462.
   PubMed Web of Science ®Google Scholar
• Maurelli M, Colato C, Gisondi P, et al. Primary cutaneous CD4+ small/medium pleomorphic T-Cell lymphoproliferative disorder: a case series. J Cutan Med Surg. 2017;21(6):502–506.
   PubMed Web of Science ®Google Scholar
• Williams VL, Torres-Cabala CA, Duvic M. Primary cutaneous small- to medium-sized CD4 pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category. Am J Clin Dermatol. 2011;12(6):389–401.
   PubMed Web of Science ®Google Scholar
• Maurelli M, Tessari G, Colato C, et al. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-Centre cohort study. Eur J Dermatol. 2018;28(1):44–49.
   PubMed Web of Science ®Google Scholar
• Von Den Driesch P, Coors EA. Localized cutaneous small to medium-sized pleomorphic T-cell lymphoma: a report of 3 cases stable for years. J Am Acad Dermatol. 2002;46(4):531–535.
   PubMed Web of Science ®Google Scholar
• Khamaysi Z, Ben-Arieh Y, Izhak OB, et al. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center. Am J Dermatopathol. 2008;30(1):37–44.
   PubMed Web of Science ®Google Scholar
• Der-Petrossian M, Valencak J, Jonak C, et al. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin + dendritic cells. J Eur Acad Dermatol Venereol. 2011;25(8):922–927.
   PubMed Web of Science ®Google Scholar
• Kim Y, Vandersteen D. Primary cutaneous pleomorphic small/medium-sizedT-cell lymphoma in a young man. Br J Dermatol. 2001;144(4):903–905.
   PubMed Web of Science ®Google Scholar
• Boussault P, Tucker ML, Weschler J, et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma associated with an annular elastolytic giant cell granuloma. Br J Dermatol. 2009;160(5):1126–1128.
   PubMed Web of Science ®Google Scholar
• Gallardo F, García-Muret MP, Servitje O, et al. Cutaneous lymphomas showing prominent granulomatous component: Clinicopathological features in a series of 16 cases. J Eur Acad Dermatol Venereol. 2009;23(6):639–647.
   PubMed Web of Science ®Google Scholar
• Beltraminelli H, Leinweber B, Kerl H, et al. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol. 2009;31(4):317–322.
   PubMed Web of Science ®Google Scholar
• Liu Z, Lv G, Chen J, et al. Liu- primary cutaneous zygomycosis – MedMycol 2009 p663-8 (1).pdf. Med Mycol. 2009;47(6):663–668.
   PubMed Web of Science ®Google Scholar
• Wawrzycki B, Chodorowska G, Pietrzak A, et al. Primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide. Dermatol Ther. 2010;23(6):676–681.
   PubMed Web of Science ®Google Scholar
• Choi M, Park SY, Park HS, et al. A case of primary cutaneous CD4 positive small/medium T cell lymphoma. Ann Dermatol. 2011;23(1):76–80.
   PubMed Web of Science ®Google Scholar
• Messeguer F, Gimeno E, Agusti-Mejias A, et al. Linfoma cutáneo primario de células T pleomórficas de pequeño y mediano tamaño CD4+: a propósito de un caso con resolución espontánea primary cutaneous CD4+ small-to Medium-Sized pleomorphic T-Cell lymphoma: report of a case with spontaneous resolution. Actas Dermosifiliogr. 2011;102(8):636–638.
   PubMedGoogle Scholar
• Toberer F, Hartschuh W, Hadaschik E. Primary cutaneous CD4+ small-to medium-sized pleomorphic T-cell lymphoma temporary remission by oral doxycycline. JAMA Dermatol. 2013;149(8):956–959.
   PubMed Web of Science ®Google Scholar
• Zhang L, Shao H. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells. J Cutan Pathol. 2013;40(8):720–724.
   PubMed Web of Science ®Google Scholar
• Garrido MC, Riveiro-falkenbach E, Ruano Y, et al. Primary cutaneous small/medium CD4 + T-Cell lymphoma occurring during treatment with vemurafenib for advanced melanoma. Am J Dermatopathol. 2015;37(6):440–443.
   PubMed Web of Science ®Google Scholar
• González Fernández D, Valdés Pineda F, Gómez Díez S, et al. Primary cutaneous CD4+ small/medium-sized T-cell lymphoma with spontaneous regression after biopsy. Actas Dermosifiliogr. 2015;106(9):767–768.
   PubMedGoogle Scholar
• Wang L, Wang G, Gao T. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. J Cutan Pathol. 2015;42(4):265–270.
   PubMed Web of Science ®Google Scholar
• Ayala D, Ramón MD, Cabezas M, et al. Linfoma cutáneo primario de células T pleomórficas de pequeño y mediano tamaño CD4+ con expresión de marcadores de linfocito T helper folicular y resolución espontánea. Actas Dermosifiliogr. 2016;107(4):357–359.
   PubMedGoogle Scholar
• Leinweber B, Beltraminelli H, Kerl H, et al. Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases. Dermatology. 2009;219(1):42–47.
   PubMed Web of Science ®Google Scholar
• García de la Fuente MR, Vilardell-Villellas F, Martí-Laborda RM, et al. Linfoma cutáneo primario T CD4+ de célula pequeña/mediana, granulomatoso. Actas Dermosifiliogr. 2016;107(1):86–88.
   PubMedGoogle Scholar
• Hou S, Liu X, Liu J, et al. A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma. Eur J Dermatol. 2016;26(6):629–630.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Moon IJ, Won CH, et al. Facial swelling: an atypical presentation of cutaneous lymphoma. Int J Dermatol. 2016;55(8):e440–e446.
   PubMed Web of Science ®Google Scholar
• Ma H, Qiu S, Lu R, et al. Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma. An Bras Dermatol. 2016;91(3):368–371.
   PubMed Web of Science ®Google Scholar
• Topal IO, Goncu EK, Ozekinci S, et al. Primary cutaneous CD4(+) small/medium-sized T-cell lymphoma of the face: successful treatment with radiation therapy. J Dtsch Dermatol Ges. 2016;14(5):522–524.
   Web of Science ®Google Scholar
• Yasuda M, Igarashi N, Nagai Y, et al. Primary cutaneous CD4+ small/medium T-cell lymphoma with aggressive clinical course. Australas J Dermatol. 2014;55(4):304–306.
   PubMed Web of Science ®Google Scholar
• Davick JJ, Gaughan E, Barry M, et al. Primary cutaneous small/medium CD4+ T-CELL lymphoproliferative disorder occurring in a patient with metastatic melanoma. Am J Dermatopathol. 2018;40(1):60–63.
   PubMed Web of Science ®Google Scholar
• Shakerian B, Razavi N, Mandegar M. Primary cutaneous CD4-positive small/medium- sized pleomorphic T-cell lymphoma following heart transplantation. Int J Organ Transplant Med. 2017;8(3):168–169.
   PubMed Web of Science ®Google Scholar
• Jain G, Aiyer H. Primary cutaneous CD4 positive small/medium T cell lymphoma Gaurav. Indian J Dermatol Venereol Leprol. 2018;84(2):186–115.
   PubMed Web of Science ®Google Scholar
• Xu J, Huang Q. Primary cutaneous small/medium CD4+ T-cell lymphoproliferative disorder. Blood. 2018;132(7):765.
   PubMed Web of Science ®Google Scholar
• Çetinözman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic t-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol. 2012;36(1):109–116.
   PubMed Web of Science ®Google Scholar
• Valentim FDO, Oliveira CC, Miot HA. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. An Bras Dermatol. 2019;94(1):99–101.
   PubMed Web of Science ®Google Scholar
• Pérez González YC, Llamas Velasco MDM, Díaz Recuero JL, et al. Adnexotropism as a histopathological clue for the diagnosis of primary cutaneous CD4+ small/medium-sized T-cell lymphoproliferative disorder. Am J Dermatopathol. 2020;42(5):383–384.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Lomba E, Lobato-Berezo A, Pulido-Pérez A, et al. Dermoscopy of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol. 2020;59(6):755–757.
   PubMed Web of Science ®Google Scholar
• Geller S, Myskowski PL, Pulitzer M, et al. Cutaneous T-cell lymphoma (CTCL), rare subtypes: Five case presentations and review of the literature. Chin. Clin. Oncol. 2019;8(1):5–5.
   PubMed Web of Science ®Google Scholar
• Koper M, Putała-Pośpiech M, Biernat W, et al. Primary cutaneous CD4+ small-/medium-sized T-cell lymphoproliferative disorder: a case report. Clin Case Rep. 2019;7(4):703–706.
   PubMed Web of Science ®Google Scholar
• Escanilla C, Guavita Falla PM, Cevallos C, et al. Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder: the first-reported Latin-American case with response to doxycycline. Clin Case Rep. 2019;7(12):2405–2409.
   PubMed Web of Science ®Google Scholar
• Dimassi AB, Howlett C, Phua CW. Multifocal CD4+ primary cutaneous small/medium lymphoproliferative disorder successfully treated with low-dose oral methotrexate: a case report. Cureus. 2020;12(6):e8534.
   PubMed Web of Science ®Google Scholar
• Aria AB, Wilmas K, Kim EJ, et al. The development of primary cutaneous CD4+ small/medium-sized pleomorphic t-cell lymphoproliferative disorder at the site of a melanoma excision scar. Dermatol Online J. 2018;24:7.
   Google Scholar
• Magro CM, Ruan J, Grossman M, et al. Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders. Ann Diagn Pathol. 2019;40:94–104.
   PubMed Web of Science ®Google Scholar
• Pileri A, Agostinelli C, Sabattini E, et al. Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy. J Eur Acad Dermatol Venereol. 2018;32(8):e318–e321.
   PubMed Web of Science ®Google Scholar
• Garcia-Herrera A, Colomo L, Camós M, et al. Primary cutaneous small/medium CD4 + T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol. 2008;26(20):3364–3371.
   PubMed Web of Science ®Google Scholar
• Besch-Stokes JG, Costello CM, Severson KJ, et al. Primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder: diagnosis and management. J Am Acad Dermatol. 2022;86(5):1167–1169.
   PubMed Web of Science ®Google Scholar
• James E, Sokhn JG, Gibson JF, et al. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature. Leuk Lymphoma. 2015;56(4):951–957.
   PubMed Web of Science ®Google Scholar
• Virmani P, Jawed S, Myskowski PL, et al. Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience. Int J Dermatol. 2016;55(11):1248–1254.
   PubMed Web of Science ®Google Scholar
• Rodríguez Pinilla SM, Roncador G, Rodríguez-Peralto JL, et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol. 2009;33(1):81–90.
   PubMed Web of Science ®Google Scholar
• González Fernández D, Valdés Pineda F, Gómez Díez S, et al. Linfoma primario cutáneo T CD4 positivo de linfocitos de pequeño y mediano tamaño con regresión espontánea tras la biopsia. Actas Dermosifiliogr. 2015;106(9):767–768.
   PubMedGoogle Scholar
• Ponti R, Fierro MT, Quaglino P, et al. TCRγ-Chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-Cell lymphoma samples. J Invest Dermatol. 2008;128(4):1030–1038.
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713–1723.
   PubMed Web of Science ®Google Scholar
• Olsen EA. Evaluation, diagnosis, and staging of cutaneous lymphoma. Dermatol Clin. 2015;33(4):643–654.
   PubMed Web of Science ®Google Scholar
• Phillips GS, Freret ME, Friedman DN, et al. Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer. JAMA Dermatol. 2020;156(9):963–972.
   PubMed Web of Science ®Google Scholar
• Thomas TO, Agrawal P, Guitart J, et al. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J Radiat Oncol. 2013;85(3):747–753.
   PubMed Web of Science ®Google Scholar
• Ávila M, Patel L, López S, et al. Patient-reported outcomes after treatment for clinically localized prostate cancer: a systematic review and meta-analysis. Cancer Treat Rev. 2018;66:23–44.
   PubMed Web of Science ®Google Scholar
• Liu R, Wang X, Jh T, et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. 2014;2014:CD007563.
   Google Scholar
• Kauer-Dorner D, Berger D. The role of brachytherapy in the treatment of breast cancer. Breast Care. 2018;13(3):157–161.
   PubMed Web of Science ®Google Scholar
• Martínez-Fernández MI, Alcalde J, Cambeiro M, et al. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: results of a phase I/II reirradiation study. Radiother Oncol. 2017;122(2):255–259.
   PubMed Web of Science ®Google Scholar
• Takácsi-Nagy Z, Martínez-Mongue R, Mazeron J-J, et al. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies. Brachytherapy. 2017;16(1):44–58.
   PubMed Web of Science ®Google Scholar
• Desimone JA, Guenova E, Carter JB, et al. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2013;69(1):61–65.
   PubMed Web of Science ®Google Scholar
• Guix B, Finestres F, Tello JI, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys. 2000;47(1):95–102.
   PubMed Web of Science ®Google Scholar
• Patel RR, Strimling R, Willoughby M, et al. Comparison of electronic brachytherapy and mohs micrographic surgery—a matched pair cohort study for treatment of non-melanoma skin cancer. Int J Radiat Oncol. 2017;9:338–344.
   Google Scholar